These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11373631)

  • 41. [Genetic modification of animals, is it allowable?].
    Wijsmuller JM
    Tijdschr Diergeneeskd; 1993 Oct; 118(19):620-3. PubMed ID: 8211922
    [No Abstract]   [Full Text] [Related]  

  • 42. Slaughter of infant calves.
    Tuckey JB
    Vet Rec; 1999 Sep; 145(12):352. PubMed ID: 10530886
    [No Abstract]   [Full Text] [Related]  

  • 43. German changes face opposition.
    Abbott A
    Nature; 1993 Oct; 365(6448):684. PubMed ID: 8413636
    [No Abstract]   [Full Text] [Related]  

  • 44. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M; Ohta K
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Polymorphism of length of tetranucleotide repeat from the 5'-side from the myelin basic protein gene in multiple sclerosis in Russians].
    Andreevskiĭ TV; Guérini FR; Sudomoina MA; Boĭko AN; Alekseenkov AD; Kulakova OG; Kitsuake K; Ferrabte O; Gusev EI; Favorova OO
    Mol Biol (Mosk); 2003; 37(6):999-1006. PubMed ID: 14714495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Zealand backs GM technologies.
    Norrie C
    Nat Biotechnol; 2001 Sep; 19(9):792. PubMed ID: 11533620
    [No Abstract]   [Full Text] [Related]  

  • 48. GM cows face slaughter in multiple sclerosis experiment.
    Brockie B
    Nature; 2001 May; 411(6836):402. PubMed ID: 11373631
    [No Abstract]   [Full Text] [Related]  

  • 49. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
    Fontoura P; Garren H; Steinman L
    Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MRI-guided immunotherapy development for multiple sclerosis in a primate.
    't Hart BA; Smith P; Amor S; Strijkers GJ; Blezer EL
    Drug Discov Today; 2006 Jan; 11(1-2):58-66. PubMed ID: 16478692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic alterations in the mouse myelin basic proteins result in a range of dysmyelinating disorders.
    Jacobs EC
    J Neurol Sci; 2005 Feb; 228(2):195-7. PubMed ID: 15694204
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.